251 related articles for article (PubMed ID: 20739455)
1. Tolerance to the antinociceptive effect of morphine in the absence of short-term presynaptic desensitization in rat periaqueductal gray neurons.
Fyfe LW; Cleary DR; Macey TA; Morgan MM; Ingram SL
J Pharmacol Exp Ther; 2010 Dec; 335(3):674-80. PubMed ID: 20739455
[TBL] [Abstract][Full Text] [Related]
2. Tolerance to repeated morphine administration is associated with increased potency of opioid agonists.
Ingram SL; Macey TA; Fossum EN; Morgan MM
Neuropsychopharmacology; 2008 Sep; 33(10):2494-504. PubMed ID: 18046309
[TBL] [Abstract][Full Text] [Related]
3. Differential development of antinociceptive tolerance to morphine and fentanyl is not linked to efficacy in the ventrolateral periaqueductal gray of the rat.
Bobeck EN; Haseman RA; Hong D; Ingram SL; Morgan MM
J Pain; 2012 Aug; 13(8):799-807. PubMed ID: 22766006
[TBL] [Abstract][Full Text] [Related]
4. Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey.
Wilson-Poe AR; Lau BK; Vaughan CW
Br J Pharmacol; 2015 Jan; 172(2):681-90. PubMed ID: 24916363
[TBL] [Abstract][Full Text] [Related]
5. Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine.
Bagley EE; Chieng BC; Christie MJ; Connor M
Br J Pharmacol; 2005 Sep; 146(1):68-76. PubMed ID: 15980868
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by opioids acting on mu-receptors of GABAergic and glutamatergic postsynaptic potentials in single rat periaqueductal gray neurones in vitro.
Chieng B; Christie MJ
Br J Pharmacol; 1994 Sep; 113(1):303-9. PubMed ID: 7812626
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of the excitatory action of NMDA in ventrolateral periaqueductal gray by the mu-opioid receptor agonist, DAMGO.
Kow LM; Commons KG; Ogawa S; Pfaff DW
Brain Res; 2002 May; 935(1-2):87-102. PubMed ID: 12062477
[TBL] [Abstract][Full Text] [Related]
8. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
Smith PA; Selley DE; Sim-Selley LJ; Welch SP
Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
[TBL] [Abstract][Full Text] [Related]
9. Chronic morphine reduces the readily releasable pool of GABA, a presynaptic mechanism of opioid tolerance.
Wilson-Poe AR; Jeong HJ; Vaughan CW
J Physiol; 2017 Oct; 595(20):6541-6555. PubMed ID: 28815604
[TBL] [Abstract][Full Text] [Related]
10. Hyperpolarization by opioids acting on mu-receptors of a sub-population of rat periaqueductal gray neurones in vitro.
Chieng B; Christie MJ
Br J Pharmacol; 1994 Sep; 113(1):121-8. PubMed ID: 7812601
[TBL] [Abstract][Full Text] [Related]
11. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
[TBL] [Abstract][Full Text] [Related]
12. Neuroadaptation of GABAergic transmission in the central amygdala during chronic morphine treatment.
Bajo M; Roberto M; Madamba SG; Siggins GR
Addict Biol; 2011 Oct; 16(4):551-64. PubMed ID: 21182569
[TBL] [Abstract][Full Text] [Related]
13. Chronic inflammatory pain prevents tolerance to the antinociceptive effect of morphine microinjected into the ventrolateral periaqueductal gray of the rat.
Mehalick ML; Ingram SL; Aicher SA; Morgan MM
J Pain; 2013 Dec; 14(12):1601-10. PubMed ID: 24161274
[TBL] [Abstract][Full Text] [Related]
14. G protein-coupled receptor kinase 2 mediates mu-opioid receptor desensitization in GABAergic neurons of the nucleus raphe magnus.
Li AH; Wang HL
J Neurochem; 2001 Apr; 77(2):435-44. PubMed ID: 11299306
[TBL] [Abstract][Full Text] [Related]
15. Capsaicin in the periaqueductal gray induces analgesia via metabotropic glutamate receptor-mediated endocannabinoid retrograde disinhibition.
Liao HT; Lee HJ; Ho YC; Chiou LC
Br J Pharmacol; 2011 May; 163(2):330-45. PubMed ID: 21232043
[TBL] [Abstract][Full Text] [Related]
16. Opioid receptor internalization contributes to dermorphin-mediated antinociception.
Macey TA; Ingram SL; Bobeck EN; Hegarty DM; Aicher SA; Arttamangkul S; Morgan MM
Neuroscience; 2010 Jun; 168(2):543-50. PubMed ID: 20394808
[TBL] [Abstract][Full Text] [Related]
17. Effect of the {mu} opioid on excitatory and inhibitory synaptic inputs to periaqueductal gray-projecting neurons in the amygdala.
Finnegan TF; Chen SR; Pan HL
J Pharmacol Exp Ther; 2005 Feb; 312(2):441-8. PubMed ID: 15388784
[TBL] [Abstract][Full Text] [Related]
18. β-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons.
Connor M; Bagley EE; Chieng BC; Christie MJ
Br J Pharmacol; 2015 Jan; 172(2):492-500. PubMed ID: 24597632
[TBL] [Abstract][Full Text] [Related]
19. The functional antiopioid action of the ventrolateral periaqueductal gray nociceptin/orphanin FQ and nociceptin receptor system underlies DAMGO analgesic tolerance.
Parenti C; Scoto GM
Pharmacology; 2010; 86(3):138-44. PubMed ID: 20689345
[TBL] [Abstract][Full Text] [Related]
20. Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats.
Lane DA; Patel PA; Morgan MM
Neuroscience; 2005; 135(1):227-34. PubMed ID: 16084660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
